A proposed definition of remission from chronic pain, based on retrospective evaluation of 24-month outcomes with spinal cord stimulation

ABSTRACT Objective: In the treatment of chronic diseases, remission is commonly used as a meaningful treatment goal, synonymous with the absence of significant clinical signs and symptoms of a disease, but not representing a cure. The objective of this paper is to propose a definition for remission for use as an outcome to evaluate the long-term efficacy of therapies for chronic pain. Methods: Data from a randomized clinical trial (NCT01609972) testing the efficacy of spinal cord stimulation in low back and leg pain subjects was used to evaluate the association between pain and functional outcomes and identify the cut-off value to predict remission. Available data over 24-month assessment period included visual analog score (VAS), disability (Oswestry Disability Index [ODI]), patient and clinician global impression of change (PGIC and CGIC), and patient satisfaction. Cluster analysis, Pearson’s correlation coefficients, sensitivity, and specificity analyses were used to evaluate its utility in predicting higher patient functionality and satisfaction. Results: Though the term remission has been used in the chronic pain field, a consistent definition has not been previously established. Based on the analysis of the clinical data, we propose that a sustained (≥6 months) pain score of ≤3.0 cm out of 10 cm on VAS be defined as remission. Applying this definition to the clinical trial data: subjects in remission at 24 months versus non-remitters were significantly more likely to be in the highest functional category of minimally disabled according to the ODI (31.5 vs. 8.2%, respectively, p = 0.001), and be ‘very satisfied’ (75.7 vs 22.6%, respectively, p < 0.001). Conclusions: The validity of the proposed definition of remission is supported by the persistence of remission in this study group, and its correspondence with patient satisfaction, and reduced disability. Further evaluation of the definition using clinical data from other long-term studies is needed. Trial registration: ClinicalTrials.gov identifier: NCT01609972.

[1]  B. T. Sitzman,et al.  Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-Month Results From a Multicenter, Randomized, Controlled Pivotal Trial , 2016, Neurosurgery.

[2]  A. Shmagel,et al.  Epidemiology of Chronic Low Back Pain in US Adults: Data From the 2009–2010 National Health and Nutrition Examination Survey , 2016, Arthritis care & research.

[3]  Thomas L Yearwood,et al.  Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial , 2015, Anesthesiology.

[4]  Safdar N. Khan,et al.  A proposed set of metrics for standardized outcome reporting in the management of low back pain , 2015, Acta orthopaedica.

[5]  C. Allaart,et al.  Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment. , 2015, Rheumatology.

[6]  A. Boonstra,et al.  Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain , 2014, PAIN®.

[7]  M. Rowbotham,et al.  Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations , 2012, PAIN.

[8]  M. McGirt,et al.  Evaluating Common Outcomes for Measuring Treatment Success for Chronic Low Back Pain , 2011, Spine.

[9]  David T Felson,et al.  UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .

[10]  A. Šimundić Measures of Diagnostic Accuracy: Basic Definitions , 2009, EJIFCC.

[11]  E. Hurwitz,et al.  Does Minor Trauma Cause Serious Low Back Illness? , 2006, Spine.

[12]  E. Carragee,et al.  Low-Pressure Positive Discography in Subjects Asymptomatic of Significant Low Back Pain Illness , 2006, Spine.

[13]  G. Ramos Efficacy of vertebral axial decompression on chronic low back pain: study of dosage regimen , 2004, Neurological research.

[14]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[15]  P. Bijur,et al.  Reliability of the visual analog scale for measurement of acute pain. , 2001, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  M. Thase,et al.  Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. , 2001, The Journal of clinical psychiatry.

[17]  P. Pynsent,et al.  The Oswestry Disability Index. , 2000, Spine.

[18]  S. Mercadante Opioid responsiveness in patients with advanced head and neck cancer , 1998, Supportive Care in Cancer.

[19]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[20]  D J Kupfer,et al.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. , 1991, Archives of general psychiatry.

[21]  E. Huskisson Measurement of pain. , 1974, Lancet.

[22]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.